Albuminuria as a marker of systemic congestion in patients with heart failure
European Heart Journal

Abstract
Albuminuria is common in patients with heart failure and associated with worse outcomes. The underlying pathophysiological mechanism of albuminuria in heart failure is still incompletely understood. The association of clinical characteristics and biomarker profile with albuminuria in patients with heart failure with both reduced and preserved ejection fractions were evaluated.
Two thousand three hundred and fifteen patients included in the index cohort of BIOSTAT-CHF were evaluated and findings were validated in the independent BIOSTAT-CHF validation cohort (1431 patients). Micro-albuminuria and macro-albuminuria were defined as urinary albumin–creatinine ratio (UACR) >30 mg/gCr and >300 mg/gCr in spot urines, respectively. The prevalence of micro- and macro-albuminuria was 35.4% and 10.0%, respectively. Patients with albuminuria had more severe heart failure, as indicated by inclusion during admission, higher New York Heart Association functional class, more clinical signs and symptoms of congestion, and higher concentrations of biomarkers related to congestion, such as biologically active adrenomedullin, cancer antigen 125, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) (all
In patients with new-onset or worsening heart failure, albuminuria is consistently associated with clinical, echocardiographic, and circulating biomarkers of congestion.
Contributors

Eva M Boorsma
Author

Jozine M ter Maaten
Author

Bart J van Essen
Author

Nilesh J Samani
Author

Kenneth Dickstein
Author

Gerasimos Filippatos
Author

Chim C Lang
Author

Leong Ng
Author

John G Cleland
Author

Pierpaolo Pellicori
Author
University of Glasgow Glasgow , United Kingdom of Great Britain & Northern Ireland

Ron T Gansevoort
Author

Hiddo J L Heerspink
Author

Johanna E Emmens
Author
You may be interested in










